News

Novo Nordisk has promoted Rishang Deoras to Global Director - Diabetes Commercial Unit.Deoras shared the news in a LinkedIn ...
Michael Field, chief EMEA equity strategist at Morningstar, discusses European stocks amid tariff uncertainty. Despite a court order, White House bars AP from Oval Office event Actors Who Refused ...
Camilla repurposed her ivory gown and coat for her state visit to Italy with her husband, King Charles Charna Flam is a writer-reporter at PEOPLE. She has been working at PEOPLE since 2023. Her ...
Like Queen Elizabeth, she loves horses and a great tiara moment. Vatican via Getty King Charles and Queen Camilla are saying "ciao" to Pope Francis after all. On April 9, the King and Queen ...
King Charles and Queen Camilla are celebrating their 20-year wedding anniversary on 9 April, and to mark the special event, the Queen has reworn her wedding outfit. Her Majesty stepped out in the ...
Henvender sig til alle, der arbejder med energi, affaldshåndtering og vandforsyning, og som vil følge de politiske kampe og beslutninger på områderne.Henvender sig til alle, der arbejder med energi, ...
So was the case with a particular brooch Queen Camilla wore this week while in Italy with husband King Charles—a trip that also coincided with their landmark 20th wedding anniversary.
In this exclusive interview, Business Today speaks with Vikrant Shrotriya, Managing Director of Novo Nordisk India, about the significance of semaglutide (the active ingredient in Wegovy), its ...
Queen Camilla's transformation from vilified mistress to highly-respected member of the Firm has been documentated in front of our eyes. With the King by her side, Camilla, 77, has expertly grown ...
While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire across the globe and make inroads into large markets like Brazil.
Novo Nordisk A/S has a fifty-two week low of $60.61 and a fifty-two week high of $148.15. The company has a market capitalization of $285.03 billion, a price-to-earnings ratio of 19.31, a P/E/G ...